Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER
    Meeting Abstract

    Strickler, J. H.; Cercek, A.; Ng, K.; Siena, S.; André, T.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A. L.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic value of KRAS and BRAF mutations in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: An ACCENT/IDEA pooled analysis of 7 trials
    Meeting Abstract

    Taieb, J.; Pederson, L.; Sinicrope, F. A.; Lonardi, S.; Alberts, S.; George, T.; Saltz, L.; Yothers, G.; Goldberg, R.; Kerr, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance)
    Meeting Abstract

    Weiser, M.; Shi, Q.; Chang, G. J.; Hakki, L.; Goldberg, J.; Auer, R.; Gollub, M.; Saltz, L.; Musher, B. L.; Al Baghdadi, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Individual patient data (IPD) meta-analysis of randomised trials to compare efficacy of second-line fluoropyrimidine-based chemotherapy in advanced biliary tract cancer (BTC)
    Meeting Abstract

    Hyung, J.; Kang, M.; Kim, I.; Kim, P.; Ryoo, B. Y.; Cheon, J.; Ryu, H.; Lee, J. S.; Abou-Alfa, G. K.; Kim, J. W.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor, in patients with advanced cholangiocarcinoma, urothelial carcinoma and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations
    Meeting Abstract

    Garmezy, B.; Borad, M.; Lin, C. C.; Chen, L. T.; Perez, C. A.; Kato, S.; Tam, B.; Severson, P.; Quah, C. S.; Harding, J. J.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study
    Meeting Abstract

    Wasan, H. S.; Harding, J. J.; Fan, J.; Oh, D. Y.; Choi, H. J.; Kim, J. W.; Chang, H. M.; Bao, L.; Sun, H.; Macarulla, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
    Journal Article

    Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J. P.; Yanez, P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Efficacy of HER2-targeted intraperitoneal (225)Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis
    Journal Article

    Chung, S. K.; Vargas, D. B.; Chandler, C. S.; Katugampola, S.; Veach, D. R.; McDevitt, M. R.; Seo, S. H.; Vaughn, B. A.; Rinne, S. S.; Punzalan, B.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: Analysis of number needed to treat and number needed to harm
    Journal Article

    Sugarman, R.; Betts, K. A.; Nie, X.; Hartman, J.; Nguyen, H.
    Clinical Therapeutics (2023)

    Fulltext@MSK | Save
  • Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up☆
    Guidelines

    Conroy, T.; Pfeiffer, P.; Vilgrain, V.; Lamarca, A.; Seufferlein, T.; O'Reilly, E. M.; Hackert, T.; Golan, T.; Prager, G.; Haustermans, K.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save